CUL9 and cancer: Seven top upregulated emRNAs and related to ccRCC or/and multiple malignant tumors, including CUL9, ATM, ARID1A, KMT2D, PBRM1, PREX2, and SETD2, were selected as candidate biomarkers for further testing.